PCN54 ESTIMATING THE CLINICAL BENEFITS OF HPV-16/18 VACCINATION- CHALLENGES OF MODELING PREDICTED CASES OF CERVICAL CANCER IN POLAND AND MEXICO, TWO COUNTRIES WITH DIFFERING DEGREES OF CERVICAL DISEASE AND POPULATION STABILITY

Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63484-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)63484-5/fulltext
Title : PCN54 ESTIMATING THE CLINICAL BENEFITS OF HPV-16/18 VACCINATION- CHALLENGES OF MODELING PREDICTED CASES OF CERVICAL CANCER IN POLAND AND MEXICO, TWO COUNTRIES WITH DIFFERING DEGREES OF CERVICAL DISEASE AND POPULATION STABILITY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63484-5&doi=10.1016/S1098-3015(10)63484-5
First page :
Section Title :
Open access? : No
Section Order : 336
Categories :
Tags :
Regions :
ViH Article Tags :